NDA/BLA filedconf 0.70

NDA/BLA filed

$NUVL · Nuvalent, Inc.

Event date

Date TBD

Sponsor runway

42 mo

$1.29B liquid

Evidence

“The Company plans to discuss the topline pivotal data for TKI pre-treated ALK-positive NSCLC with the U.S. Food and Drug Administration (the "FDA") at a pre-New Drug Application ("NDA") meeting.”

Source: 8-K filed 2025-11-17View on EDGAR ↗0001193125-25-283893

Comparable historical nda/bla fileds· last 5 years · same event type

Ticker	Drug	Date	Outcome
$AXSM	—	2025-12-31	unknown
$RCKT	kresladi	2025-10-14	unknown
$ALDX	reproxalap	2025-07-17	unknown
$ETON	et-600	2025-07-08	unknown
$BCRX	orladeyo (berotralstat)	2025-05-14	unknown
$CORT	relacorilant	2025-03-03	unknown
$ALDX	reproxalap	2024-11-01	unknown
$AXSM	axs-07	2024-09-04	unknown
$RCKT	kresladi	2023-10-02	unknown
$GERN	imetelstat	2023-08-21	unknown

Recent insider activity· ±90 days

4 insiders · 0 buys · 13 sells

Exercise10b5-1

2026-05-04

Porter James Richard

President and CEO

30,000 @ $18.93$568K

Sell10b5-1

2026-05-04

Porter James Richard

President and CEO

2,111 @ $102.88$217K

Sell10b5-1

2026-05-04

Porter James Richard

President and CEO

17,353 @ $102.10$1.77M

Sell10b5-1

2026-05-04

Porter James Richard

President and CEO

7,429 @ $101.48$754K

Sell10b5-1

2026-05-04

Porter James Richard

President and CEO

1,408 @ $99.77$140K

Sell10b5-1

2026-05-04

Porter James Richard

President and CEO

1,699 @ $98.54$167K

Sell10b5-1

2026-05-01

Balcom Alexandra

Chief Financial Officer

124 @ $99.97$12K

Exercise10b5-1

2026-05-01

Balcom Alexandra

Chief Financial Officer

7,159 @ $1.08$8K

Exercise10b5-1

2026-05-01

Balcom Alexandra

Chief Financial Officer

4,271 @ $6.89$29K

Sell10b5-1

2026-05-01

Balcom Alexandra

Chief Financial Officer

3,872 @ $98.42$381K

Sell10b5-1

2026-05-01

Balcom Alexandra

Chief Financial Officer

7,434 @ $99.29$738K

Sell10b5-1

2026-04-30

Miller Deborah Ann

Chief Legal Officer

1,082 @ $99.57$108K

Sell10b5-1

2026-04-30

Miller Deborah Ann

Chief Legal Officer

4,418 @ $99.13$438K

Exercise10b5-1

2026-04-30

Miller Deborah Ann

Chief Legal Officer

5,500 @ $6.89$38K

Sell10b5-1

2026-04-29

Noci Darlene

Chief Development Officer

700 @ $100.14$70K

Sell10b5-1

2026-04-29

Noci Darlene

Chief Development Officer

300 @ $101.17$30K

Sell10b5-1

2026-04-29

Noci Darlene

Chief Development Officer

4,500 @ $99.35$447K

Exercise10b5-1

2026-04-29

Noci Darlene

Chief Development Officer

5,500 @ $27.85$153K

Date	Insider	Action	Shares	Price	Value
2026-05-04	Porter James RichardPresident and CEO	Exercise10b5-1	30,000	$18.93	$568K
2026-05-04	Porter James RichardPresident and CEO	Sell10b5-1	2,111	$102.88	$217K
2026-05-04	Porter James RichardPresident and CEO	Sell10b5-1	17,353	$102.10	$1.77M
2026-05-04	Porter James RichardPresident and CEO	Sell10b5-1	7,429	$101.48	$754K
2026-05-04	Porter James RichardPresident and CEO	Sell10b5-1	1,408	$99.77	$140K
2026-05-04	Porter James RichardPresident and CEO	Sell10b5-1	1,699	$98.54	$167K
2026-05-01	Balcom AlexandraChief Financial Officer	Sell10b5-1	124	$99.97	$12K
2026-05-01	Balcom AlexandraChief Financial Officer	Exercise10b5-1	7,159	$1.08	$8K
2026-05-01	Balcom AlexandraChief Financial Officer	Exercise10b5-1	4,271	$6.89	$29K
2026-05-01	Balcom AlexandraChief Financial Officer	Sell10b5-1	3,872	$98.42	$381K
2026-05-01	Balcom AlexandraChief Financial Officer	Sell10b5-1	7,434	$99.29	$738K
2026-04-30	Miller Deborah AnnChief Legal Officer	Sell10b5-1	1,082	$99.57	$108K
2026-04-30	Miller Deborah AnnChief Legal Officer	Sell10b5-1	4,418	$99.13	$438K
2026-04-30	Miller Deborah AnnChief Legal Officer	Exercise10b5-1	5,500	$6.89	$38K
2026-04-29	Noci DarleneChief Development Officer	Sell10b5-1	700	$100.14	$70K
2026-04-29	Noci DarleneChief Development Officer	Sell10b5-1	300	$101.17	$30K
2026-04-29	Noci DarleneChief Development Officer	Sell10b5-1	4,500	$99.35	$447K
2026-04-29	Noci DarleneChief Development Officer	Exercise10b5-1	5,500	$27.85	$153K

← All catalysts for $NUVL